Member Info for bigpunt

For entry in to the UK market the construction method will need to be verified by a credible UK organisation that will certify the longevity of the construction for mortgage purposes

One thing we don't know is how capital intensive the franchise business is. I recall a previous comment that they are trading surprisingly well and they are expanding rapidly there with carefully selected partners. You'd think that comes from a much less capital-investment position. Therefore returns from capital employed may be improving at an increased rate

The RevPAR in the budget hotel market is down by a similar percentage

I don't worry about the hotel sales, it comes at a minimal marginal cost for such a large employer that is occupying the premises almost entirely to deliver expect bar and food sales.

So, in summary, in line with hotel market and outperforming their main market

Buy

A L/T holder should view this positively, as with almost everything over the last 2 years. However I'll be interested to see the reaction to a provision being booked

This is largely an irrelevance because hardly anybody reads them, but it is one of the most poorly written and laid out annual reports I have seen

Of course the exercise price should be reasonable, or the options do not function as an incentive.

My issue is that there is no detail on vesting conditions. However the timing is interesting, management obviously expect share price to boooooom

Yes, that is what has been said. But there has been no discussion of revenue recognition

That is a poor journal. I wouldn't even call it an academic journal because no primary research has been carried out

This was a resistance test, and it is not published as an academic journal - it is a report of limited scope, supposedly for Chile's buying decision. God only knows what the building quality is like in Chile! It doesn't support any of the various other claims on the website. In the UK we have Awaab's law coming in next week and ECOB could capture a lot of market share if they could substantiate their claims

Please share the academic journal

It's all very strange. Almost no technical detail available on the website. That tells me that it is still in prototype stage. If this was a serious product then they would have partnered with at lease one research institution to provide various thermal, adsorption/absorption, acoustic, test results.

Website states building code compliant...but which building codes!? Murky

General tip: don't buy when there are a lot of people buying

Thanks Shy

To be honest, if the book had already been built and that's why pertinent information was omitted, you could view it as extremely positive, albeit murky

Did Ashman upgrade forecasts as part of the placing? I can't find anything

"Will be stepping away"

So tell us when!

B_Positive you are fantasising...the company have not given any guidance for Q3 growth, only Q4 growth, and to think that will increase by 500 tests is utter tripe. Don't ramp expectations, use company guidance

Aquae it's a very fair point, but if that is the only 'risk' you can foresee, it is your duty as a private investor to load up at this price!

All this conspiracy theory is probably mostly correct, but quite amusing. At the end of the day, what is the downside?!

The only downside posited so far is takeover. I'm sorry, but takeover is not a downside for a shareholder because it always involves a significant premium

After a more detailed review it appears that Verici are copying the sales strategy for Tutivia that Thermo Fisher are using for the PTRA. Clearly a lot of research has already been done to get to this point in execution. For me, that is a huge positive and an endorsement of the exec

No growth in tests from Q1 to Q2 2025. At finals they said 292 for Q1 2025, therefore achieved 299 in Q2. They have signposted no growth for Q3 2025 and are anticipating "further scale up" from Q4. Even with some 'scale up' it looks like another raise in Q3 2026. However if they do get great growth between now and then, the raise could be at 5p per share